MedLife remains set to acquire Polisano Medical Services

By Catherine Sturman
It has been reported that one of the largest private Romanian healthcare companies, MedLife, is set to acquire Polisano Medical Services for an undisclo...

It has been reported that one of the largest private Romanian healthcare companies, MedLife, is set to acquire Polisano Medical Services for an undisclosed sum, subject to approval.

Situated in Romania for nearly 20 years, MedLife has been slowly diversifying and growing its portfolio to become one of the most well renowned private healthcare companies in the country. Since 2010, the company has completed over 15 acquisitions to further its dominance within the Romanian market.

“By joining the MedLife Group, Polisano will bring added value and, at the same time, it will help us sustain our commitment to continuously deliver premium services and an outstanding medical team, to all patients, both in retail zone, as well as the corporate,” explained Ovidiu Gligor, Administrator of Polisano Clinics.

MedLife strenuously works to deliver patient-centric care, and will house over 6,000 employees across its operations if a deal is finalised. It’s €17 million turnover in 2016 will also increase upon the completion of the reported acquisition.

Related stories

MedLife General Manager Mihai Marcu has said: “If all conditions are met and the acquisition of Polisano Clinics is completed, MedLife will have 6,300 employees and will be the employer of approximately 5% of doctors with Free Practice Authorisation in Romania and probably a similar percentage of nurses.”

“For us, Polisano becomes an important strategic partnership and, at the same time, a proof of our long-term commitment to expand medical excellence services to the benefit of patients in all regions of the country,” he added.

“We have a special respect for the quality of medical services and the operational functioning of Polisano. These are the values that bring us together and I am confident that Polisano will strengthen our position as a national leader in high performance medical services.”

Share

Featured Articles

Healthcare Business roundup: Baxter, Sanofi & Eli Lilly

Baxter International to sell kidney care spin-off Vantive; Sanofi's consumer health unit ‘to be separated’; Eli Lilly to buy Morphic Holding for $3.2bn

Trane Technologies Helping US Hospitals Meet Climate Pledge

Christy Fetsch of Trane Technologies explains how the company is helping US hospitals meet White House sustainability pledges for US healthcare provision

Nestlé Health Science Targets Weight Loss Side-Effects

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out 'Ozempic Face'

Eli Lilly Alzheimer's Drug Kisunla Approved in US by FDA

Medical Devices & Pharma

WEF: Gender Health Gap 'Costs women 75mn years of Life'

Medical Devices & Pharma

Schneider: Swathe of NHS Failing to Measure Sustainability

Sustainability